Teva CEO Discusses Q2 Earnings and NYSE Direct Listing

Teva Pharmaceuticals CEO Richard Francis spoke about the company's positive second-quarter earnings, the upcoming impact of changes to Medicare rules on patients, and the company's planned direct listing on the New York Stock Exchange.

29 Jul, 23:55 — 29 Jul, 23:55

Post Share

Sources

Showing 1 of 1 sources

bloombergHigh4d ago

Teva CEO on Drug Pipeline, Direct Listing on NYSE

Teva Pharmaceuticals CEO Richard Francis speaks to Bloomberg's Romaine Bostick about the company's positive Q2 earnings, the impending impact of changing Medicare rules on patients, and the new listing on the NYSE. (Source: Bloomberg)

Read full article →

PERSPECTA

PERSPECTA

Teva CEO Discusses Q2 Earnings and NYSE Direct Listing

Sources

Teva CEO on Drug Pipeline, Direct Listing on NYSE

Related Stories

GreenMobility will send driverless cars on the street in 2027

DeepSeek's New AI Model V4-Flash Priced Significantly Lower Than Competitors

US and Japan Intervene to Support Yen Amid Market Volatility

Alpha Gas SA Adds New VLAC/VLGC "Energy Guardian" to Its Fleet

PERSPECTA